newsfilter
← Latest News
PR Newswire·

Calyxt to Present at Upcoming Conferences

ROSEVILLE, Minn., May 17, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ:CLXT), a plant-based synthetic biology company, today announced that management will participate in the following upcoming investor conferences:

H.C. Wainwright Global Investment Conference

Date: May 25, 2022

Time: 11:30 am ET

Webcast: https://journey.ct.events/view/dd5ae7e1-6b52-430b-b9d8-504d330d80ad

LD Micro Invitational (XII)

Date: June 8, 2022

Time: 7:30 am ET

Webcast: https://ldinv12.mysequire.com

To schedule a meeting with management, please reach out to investors@calyxt.com.

The presentations will be available for viewing and replay from the Investors section of Calyxt's website at www.calyxt.com.

About Calyxt

Calyxt (NASDAQ:CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.

PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.

Contacts

Calyxt Media Contact:



Calyxt Investor Relations Contact:

David Rosen/ John Garabo/ Michael Barron Argot Partners

(212) 600-1902

media@calyxt.com



Kimberly Minarovich/ Cameron Willis 

Argot Partners

(212) 600-1902

investors@calyxt.com







Calyxt Business Development Contact:





Gerry Nuovo

Senior Vice President of Business Development

(612) 427-7881

contact@calyxt.com





View original content to download multimedia:https://www.prnewswire.com/news-releases/calyxt-to-present-at-upcoming-conferences-301548398.html

SOURCE Calyxt, Inc.